Search PDMR transactions

Notifier
Name of person with notification obligation
Hugo Petit
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Hugo Petit
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Lipigon Pharmaceuticals AB TO3 SE0019914102 Acquisition 200,000 Quantity 0.08 SEK 21/03/2024 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB TO3 SE0019914102 Acquisition 21/03/2024 FIRST NORTH SWEDEN 200,000 (Quantity) 0.08 SEK
<< Back